Market Analysis and Insights: Global PCR and NGS-Based Molecular Diagnostics Market
The global PCR and NGS-Based Molecular Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PCR and NGS-Based Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PCR and NGS-Based Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PCR and NGS-Based Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PCR and NGS-Based Molecular Diagnostics market.
PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
Biomarker Discovery
Blood Sample Testig
Others
PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
Hospitals
Academics/Research Institutions
Others
Based on regional and country-level analysis, the PCR and NGS-Based Molecular Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global PCR and NGS-Based Molecular Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock
The global PCR and NGS-Based Molecular Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PCR and NGS-Based Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PCR and NGS-Based Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PCR and NGS-Based Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PCR and NGS-Based Molecular Diagnostics market.
PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
Biomarker Discovery
Blood Sample Testig
Others
PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
Hospitals
Academics/Research Institutions
Others
Based on regional and country-level analysis, the PCR and NGS-Based Molecular Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global PCR and NGS-Based Molecular Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2015-2026)
2.2 Global PCR and NGS-Based Molecular Diagnostics Growth Trends by Regions
2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Market Size
3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2015-2020)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2019
3.5 Key Players PCR and NGS-Based Molecular Diagnostics Area Served
3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2021-2026)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
8.2 China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
8.3 China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
8.4 China PCR and NGS-Based Molecular Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
9.2 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
9.3 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
9.4 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
10.2 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Details
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020))
11.1.5 Thermofisher Recent Development
11.2 Illumine
11.2.1 Illumine Company Details
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.2.5 Illumine Recent Development
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Details
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.3.5 Paragon Genomics Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.4.5 Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.5.5 Qiagen Recent Development
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Details
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.6.5 Bioo Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.7.5 Agilent Recent Development
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Details
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.8.5 Pillar Biosciences Recent Development
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
11.10 iGen Technologies
11.10.1 iGen Technologies Company Details
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.10.5 iGen Technologies Recent Development
11.11 Burning Rock
10.11.1 Burning Rock Company Details
10.11.2 Burning Rock Business Overview
10.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
10.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
10.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2015-2026)
2.2 Global PCR and NGS-Based Molecular Diagnostics Growth Trends by Regions
2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Market Size
3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2015-2020)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2019
3.5 Key Players PCR and NGS-Based Molecular Diagnostics Area Served
3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2021-2026)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
8.2 China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
8.3 China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
8.4 China PCR and NGS-Based Molecular Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
9.2 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
9.3 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
9.4 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size (2015-2026)
10.2 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Details
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020))
11.1.5 Thermofisher Recent Development
11.2 Illumine
11.2.1 Illumine Company Details
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.2.5 Illumine Recent Development
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Details
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.3.5 Paragon Genomics Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.4.5 Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.5.5 Qiagen Recent Development
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Details
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.6.5 Bioo Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.7.5 Agilent Recent Development
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Details
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.8.5 Pillar Biosciences Recent Development
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
11.10 iGen Technologies
11.10.1 iGen Technologies Company Details
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
11.10.5 iGen Technologies Recent Development
11.11 Burning Rock
10.11.1 Burning Rock Company Details
10.11.2 Burning Rock Business Overview
10.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
10.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
10.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
